Growth Metrics

Collegium Pharmaceutical (COLL) Total Debt (2016 - 2026)

Collegium Pharmaceutical has reported Total Debt over the past 11 years, most recently at $559.7 million for Q4 2025.

  • For Q4 2025, Total Debt fell 3.45% year-over-year to $559.7 million; the TTM value through Dec 2025 reached $559.7 million, down 3.45%, while the annual FY2025 figure was $559.7 million, 3.45% down from the prior year.
  • Total Debt for Q4 2025 was $559.7 million at Collegium Pharmaceutical, down from $570.2 million in the prior quarter.
  • Over five years, Total Debt peaked at $630.3 million in Q3 2024 and troughed at $110.0 million in Q4 2021.
  • A 5-year average of $448.8 million and a median of $548.4 million in 2023 define the central range for Total Debt.
  • Biggest five-year swings in Total Debt: surged 409.07% in 2022 and later crashed 35.9% in 2024.
  • Year by year, Total Debt stood at $110.0 million in 2021, then surged by 409.07% to $560.1 million in 2022, then dropped by 27.68% to $405.0 million in 2023, then surged by 43.12% to $579.7 million in 2024, then fell by 3.45% to $559.7 million in 2025.
  • Business Quant data shows Total Debt for COLL at $559.7 million in Q4 2025, $570.2 million in Q3 2025, and $585.2 million in Q2 2025.